Masahiro Tabata
- Oncology top 0.5%
- Lung Cancer Research Studies 97
- Colorectal Cancer Treatments and Studies 27
- HER2/EGFR in Cancer Research 12
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations 119
- Lung Cancer Diagnosis and Treatment 33
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 10
- Molecular Biology top 10%
- Cancer therapeutics and mechanisms 34
- Otorhinolaryngology top 5%
-
- Neuroendocrine Tumor Research Advances 35
- Co-authors
- Katsuyuki KiuraMitsune TanimotoHiroshi UeokaKatsuyuki HottaNagio TakigawaKeitaro MatsuoKeiichi FujiwaraEiki Ichihara
- Journals
- Journal of Biological Chemistry (1 paper)Journal of Clinical Oncology (17 papers)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- JapanUnited StatesGreece
In The Last Decade
Masahiro Tabata
213 papers receiving 4.4k citations
Peers
Comparison fields: 5 of 111
- Oncology 2.9k
- Pulmonary and Respiratory Medicine 2.9k
- Cancer Research 606
- Molecular Biology 1.3k
- Otorhinolaryngology 61
Countries citing papers authored by Masahiro Tabata
This map shows the geographic impact of Masahiro Tabata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiro Tabata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiro Tabata more than expected).
Fields of papers citing papers by Masahiro Tabata
This network shows the impact of papers produced by Masahiro Tabata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiro Tabata. The network helps show where Masahiro Tabata may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Masahiro Tabata, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 1 | |
| 9 | 2021 | 13 | |
| 10 | 2020 | 6 | |
| 11 | 2013 | 1 | |
| 12 | Emergence of the EGFR T790M mutation in a lung adenocarcinoma cell line after vandetanib treatment | 2008 | 0 |
| 13 | 2007 | 41 | |
| 14 | 2006 | 48 | |
| 15 | Profile of phospho-proteins according to LKB1 gene status in lung cancer cells | 2005 | 1 |
| 16 | The relationship between epidermal growth factor receptor(EGFR) mutations and clinico-pathological features in non-small cell lung cancers | 2005 | 2 |
| 17 | [Combination chemotherapy with carboplatin and etoposide for elderly patients aged 76 years or older with small cell lung cancer]. | 2002 | 1 |
| 18 | 2001 | 1 | |
| 19 | 2000 | 19 | |
| 20 | 1993 | 10 |
About Masahiro Tabata
Masahiro Tabata is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 225 papers that have together received 4.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (119 papers), Lung Cancer Research Studies (97 papers), Neuroendocrine Tumor Research Advances (35 papers), Cancer therapeutics and mechanisms (34 papers), Lung Cancer Diagnosis and Treatment (33 papers), Colorectal Cancer Treatments and Studies (27 papers), HER2/EGFR in Cancer Research (12 papers) and Cancer Genomics and Diagnostics (10 papers). The work is most often cited by research in Oncology (2.9k citations), Pulmonary and Respiratory Medicine (2.9k citations) and Cancer Research (606 citations). Masahiro Tabata has collaborated with scholars based in Japan, United States and Greece. Frequent co-authors include Katsuyuki Kiura, Mitsune Tanimoto, Hiroshi Ueoka, Katsuyuki Hotta, Nagio Takigawa, Keitaro Matsuo, Keiichi Fujiwara, Eiki Ichihara, Takuo Shibayama and Yoshiro Fujiwara. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.